Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "Frazier"
showing the first 40- ANAPTYSBIO, INC (ANAB)SCHEDULE 13G/A · 2025-02-14Read the filing on SEC.gov →
- Bedell Frazier Investment Counseling, LLC13F-HR · 2022-08-03Read the filing on SEC.gov →
- Maze Therapeutics, Inc. (MAZE)SCHEDULE 13G · 2025-02-10Read the filing on SEC.gov →
- ORAPHARMA INCSC 13G · 2001-02-07Read the filing on SEC.gov →
- Oric Pharmaceuticals, Inc. (ORIC)SCHEDULE 13G/A · 2025-05-15Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2007-06-29Read the filing on SEC.gov →
- FHM IV LP4 · 2008-02-04Read the filing on SEC.gov →
- FHM IV LP4 · 2008-02-04Read the filing on SEC.gov →
- NewAmsterdam Pharma Co N.V.SC 13D/A · 2024-02-21Read the filing on SEC.gov →
- Topper James N4 · 2008-02-20Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2007-06-29Read the filing on SEC.gov →
- MACROGENICS INC (MGNX)SC 13G · 2024-11-20Read the filing on SEC.gov →
- FHM IV LP4 · 2008-03-05Read the filing on SEC.gov →
- NewAmsterdam Pharma Co N.V.SC 13D/A · 2024-12-17Read the filing on SEC.gov →
- Eledon Pharmaceuticals, Inc. (ELDN)SCHEDULE 13G/A · 2025-02-14Read the filing on SEC.gov →
- Savara Inc (SVRA)SC 13G · 2024-11-27Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-25Read the filing on SEC.gov →
- Adverum Biotechnologies, Inc. (ADVM)SC 13G · 2024-02-09Read the filing on SEC.gov →
- Lexeo Therapeutics, Inc. (LXEO)SCHEDULE 13G · 2025-06-04Read the filing on SEC.gov →
- FHM IV LP4 · 2008-02-20Read the filing on SEC.gov →
- Topper James N4 · 2008-02-04Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-25Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4/A · 2007-07-02Read the filing on SEC.gov →
- NewAmsterdam Pharma Co N.V.SC 13D/A · 2023-08-15Read the filing on SEC.gov →
- NewAmsterdam Pharma Co N.V.SC 13D/A · 2023-06-09Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-12Read the filing on SEC.gov →
- Erasca, Inc. (ERAS)SCHEDULE 13G/A · 2025-05-15Read the filing on SEC.gov →
- Elevation Oncology, Inc. (ELEV)SC 13G/A · 2024-07-15Read the filing on SEC.gov →
- Trevi Therapeutics, Inc. (TRVI)SC 13G · 2022-04-18Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-12Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-28Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-25Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-06Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-25Read the filing on SEC.gov →
- Trevi Therapeutics, Inc. (TRVI)SC 13G/A · 2022-10-07Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-02-28Read the filing on SEC.gov →
- AMICUS THERAPEUTICS INC (FOLD)4 · 2008-03-10Read the filing on SEC.gov →
- Trevi Therapeutics, Inc. (TRVI)SCHEDULE 13G/A · 2025-02-14Read the filing on SEC.gov →
- Heron Patrick J3 · 2017-01-25Read the filing on SEC.gov →
- Sierra Oncology, Inc.SC 13D/A · 2020-04-29Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001 onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.